PPD takes pharmacovigilance to BulgariaIn most industries, companies regard the issue of successfully getting productsavai...
fortunes, but also the increasing demand that is emerging for pharmacovigilanceservices across the globe. In a way its imp...
Upcoming SlideShare
Loading in …5
×

Ppd takes pharmacovigilance to bulgaria

467 views

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
467
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Ppd takes pharmacovigilance to bulgaria

  1. 1. PPD takes pharmacovigilance to BulgariaIn most industries, companies regard the issue of successfully getting productsavailable on a wide scale as the biggest challenge facing them. However, this isnot the case in the world of pharmaceuticals, as the projects of drug developmentfirms do not necessarily end when their latest items hit the shelves.This is generally where pharmacovigilance – the ongoing assessment of drugs forevidence of potential new hazards to patients – tends to come in. As suchservices play a key role in ensuring medicines remain suitable for consumersacross the globe, many companies that specialise in the area have sprung up inrecent years. In addition, a number of others have enjoyed major growth.One firm that falls into the latter category is PPD, a leading global contractresearch organisation with around 25 years of experience in drug discovery,development and lifecycle management services. Notably, the organisation hasmuch experience in the world of pharmacovigilance and is looking to take theconcept into new territories across the globe.The company recently opened a new centre in Sofia, Bulgaria, where its staff willprovide medical information call centre support and scientists will also be on handto work on pharmacovigilance projects.More specifically, the experts will consider a number of issues including adverseevent capture, safety case processing and reporting, and periodic writingservices. As the area is home to several medical and pharmacy schools, thecentre is likely to be able to recruit highly-trained healthcare professionals withextensive language capabilities locally. Nurses, physicians and pharmacists will beemployed on-site, as PPD aims to have more than 200 professionals workingthere within the next 12 months.Dr Christine Dingivan, chief medical officer at PPD, suggested the decision toestablish the base in Bulgaria was driven by rising demand for pharmacovigilanceacross the globe. "Expanding our safety and medical communications operationsin Europe strengthens our ability to bring high-quality global healthcare expertiseto provide these services in an efficient, cost-effective and regulatory compliantmanner," she explained."There is strong demand for both pre and post-approval safety services, and wehave an experienced management team on the ground in Bulgaria to oversee ouroperations and to create customised programs that meet client needs."The new site in Sofia will be PPDs third European hub, as it already runsoperations from a facility in Athlone, Ireland, as well as contact centre services inthe Swedish capital Stockholm.While the move is set to bring major benefits to the company, particularlythrough expanding the range of the companys pharmacovigilance services, thecountry of Bulgaria is also likely to prosper.James Warlick, the US ambassador to Bulgaria, said PPD was making "asignificant investment" in an "important technical field" which could play a majorpart in the countrys future. "Bulgaria has a noteworthy and rich history ofinnovation and technology, and both PPD and the people of Bulgaria can benefitfrom this venture," he explained."The US Embassy looks forward to further strengthening our relationship withPPD as it expands in this region."The growth that PPD is enjoying is not only evidence of the firms own good
  2. 2. fortunes, but also the increasing demand that is emerging for pharmacovigilanceservices across the globe. In a way its importance should not be surprising,particularly as drug developers could put their reputations – and potentially thelives of patients – in jeopardy by failing to take the concept into account.As drug safety remains such a fundamental aspect of the pharmaceuticalindustry, it is likely that more firms will experience similar growth to PPD – whichin turn will make pharmacoviligance a truly global concern.DirectNews11/05/10Found this interesting?You may like to also have a look at Adverse Event Reporting - Online TrainingCourse

×